CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug stop transplant rejection in kids?
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can lower the chance of graft-versus-host disease (GVHD) in children, teens, and young adults getting a bone marrow or blood stem cell transplant for blood cancers. About 43 participants will receive vorinostat …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:56 UTC
-
New hope for CML patients: asciminib trial shows promise
Disease control OngoingThis study tests a drug called asciminib in people with chronic-phase chronic myeloid leukemia (CML). It includes patients who have already tried one other treatment and those newly diagnosed. The goal is to see if the drug can reduce cancer cells to very low levels. Participants…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:48 UTC